Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
LifeLink Ventures is a venture capital firm founded in 2020 and headquartered in Barcelona, Spain. The firm focuses on bridging the gap between private capital and innovative investment opportunities in the life sciences sector, particularly those addressing global health challenges. LifeLink Ventures aims to support companies that are making significant contributions to global health through novel therapies.
Currently, LifeLink Ventures manages a portfolio of 12 companies, primarily in the biotech and healthcare sectors. The firm emphasizes a data-driven approach to due diligence, leveraging scientific expertise to identify promising investment opportunities. LifeLink Ventures has established a reputation for building long-term relationships with founders, providing not just capital but also strategic guidance and support to navigate the complexities of the biotech landscape.
LifeLink Ventures primarily invests in early-stage health and biotech companies across North America and Europe. The firm targets companies developing differentiated therapies for challenging health conditions, particularly those with high unmet medical needs. Their investment strategy is flexible, allowing for a range of check sizes and follow-on investments, which enables them to effectively support their portfolio companies throughout their growth stages.
The firm seeks to partner with companies that are pioneering novel therapies and technologies in the life sciences sector. LifeLink Ventures values highly differentiated companies that target clear health challenges, ensuring that their investments align with their mission to improve global health outcomes.
LifeLink Ventures has invested in a diverse range of companies within the biotech and healthcare sectors. Notable portfolio companies include:
This portfolio reflects LifeLink Ventures' commitment to supporting innovative companies that are addressing significant health challenges through advanced therapies.
Francisca Peixoto - Partner: Previously served as Chief Science Officer at WEcubed Partners, where she led scientific due diligence for biotech investment opportunities. She has a strong background in scientific operations.
Leo Figueiredo - Partner: Brings extensive experience in venture capital and a deep understanding of the biotech landscape.
Ricardo Salomao - Partner: Focuses on identifying and evaluating investment opportunities in the life sciences sector.
Ana Duran - Associate: Supports the investment team with research and analysis of potential portfolio companies.
Pablo Heredia - Analyst: Conducts due diligence and market analysis for prospective investments.
Pablo Ventós - Junior Analyst Intern: Assists in research and analysis tasks within the firm.
Alba Schmahl - Junior Analyst Intern: Provides support in evaluating investment opportunities and market trends.
Thiago Figueiredo - Advisor: Offers strategic insights and guidance based on his extensive experience in the industry.
Afonso Sá - Back Office: Manages operational aspects of the firm.
Ellie Peixoto - Community Manager: Engages with the startup community and fosters relationships with founders.
Founders interested in pitching LifeLink Ventures should submit their proposals through the firm's website or via email at info@lifelinkventures.com. A well-structured pitch deck should include details about the company's mission, market opportunity, competitive landscape, and financial projections. LifeLink Ventures appreciates concise and clear presentations that highlight the innovation and potential impact of the proposed solutions.
Response times may vary, but founders can expect feedback within a few weeks. Warm introductions are preferred but not mandatory.
In 2022, LifeLink Ventures confirmed its investment activity, focusing on early-stage biotech companies. The firm has been actively involved in supporting its portfolio companies through various stages of development.
In 2025, LifeLink Ventures continued to expand its portfolio, reinforcing its commitment to investing in innovative health solutions. The firm remains engaged in the biotech sector, monitoring emerging trends and opportunities.
What stages does LifeLink Ventures invest in?
LifeLink Ventures invests in early-stage companies, including Pre-seed, Seed, Seed+ (Extension), Series A, and Series B rounds.
What is the typical check size for investments?
The firm typically participates in rounds averaging around $47 million, often in larger syndicated investments.
What sectors does LifeLink Ventures focus on?
LifeLink Ventures primarily focuses on the biotech and healthcare sectors, particularly companies developing novel therapies for diseases with high unmet medical needs.
How can founders pitch LifeLink Ventures?
Founders can pitch LifeLink Ventures through their website at lifelinkventures.com or by emailing info@lifelinkventures.com. A clear presentation of the company's value proposition and market potential is essential.
What makes LifeLink Ventures different from other investors?
LifeLink Ventures emphasizes data-driven due diligence grounded in scientific expertise, fostering long-term relationships with founders and providing strategic guidance beyond capital.
What geographic areas does LifeLink Ventures target?
The firm primarily targets investments in North America and Europe, leveraging research hubs across both regions to identify promising opportunities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.